Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200,000
Closed -$398K 596
2025
Q2
$398K Buy
+200,000
New +$366K 0.02% 452

RBF Capital's HLVX Position: Q3 2025 in Review

RBF Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 200,000 shares — an estimated $398K sold.

RBF Capital first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $398K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • RBF Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • RBF Capital sold 200,000 HilleVax shares in Q3 2025, an estimated $398K.
  • RBF Capital first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • RBF Capital's HilleVax position peaked at $398K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on RBF Capital's 13F filing for Q3 2025, filed 14 Nov 2025.